Copyright
©The Author(s) 2018.
World J Gastroenterol. Dec 28, 2018; 24(48): 5491-5504
Published online Dec 28, 2018. doi: 10.3748/wjg.v24.i48.5491
Published online Dec 28, 2018. doi: 10.3748/wjg.v24.i48.5491
Figure 1 Experimental treatment scheme.
A: Near-infrared photoimmunotherapy (NIR-PIT); B: NIR light alone; C: Indocyanine green-labeled antibody 1849 conjugate alone; D: Anti-tissue factor antibody 1849 alone; E: Control (untreated). Anti-TF 1849: Anti-tissue factor antibody 1849; 1849-ICG: Indocyanine green-labeled anti-tissue factor antibody 1849; NIR: Near-infrared; NIR-PIT: Near-infrared photoimmunotherapy.
- Citation: Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. World J Gastroenterol 2018; 24(48): 5491-5504
- URL: https://www.wjgnet.com/1007-9327/full/v24/i48/5491.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i48.5491